Adani Ports reported consolidated revenue growth of 12% for Q2 FY27, led by its Ayush & Herbal Medicine division, which contributed 13.7% of the total. Operating margin held at 4.4%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.
The company also announced a new facility near Mundra, designed to add about 654 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.
The numbers
Capital expenditure guidance was raised to $6 billion for the fiscal year, from $125 million previously. Management said the increase reflects accelerated spending on automation and on debottlenecking existing lines, which it expects to deliver 4.4% more output without additional land.
Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.
By the numbers
Export performance was a bright spot. Shipments to Indonesia rose 12%, helped by certification wins and shorter lead times from Mundra. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.
“The pact is not just volume; it is a joint roadmap for higher-value products.”
Expansion and capital allocation
Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2030, and disclosed that 13.7% of electricity at its main sites now comes from renewable sources under long-term contracts.
Source: IGEN Intelligence analysis of un comtrade data. Illustrative mock data.
Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $125 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.
| Segment | Revenue | YoY | Margin |
|---|---|---|---|
| Ayush & Herbal Medicine (core) | $134M | +18% | 14.4% |
| Exports | $260M | +15% | 12.9% |
| Domestic retail | $59M | +12.3% | 8.6% |
| Services | $306M | +10.5% | 12.3% |
| Other | $244M | +11.1% | 22.2% |
Customers, contracts and exports
On the post-results call, management said the order book now stands at $6 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in Indonesia and Singapore. The chief financial officer described visibility as the best in five years.
Timeline of key events
- Results announced
Revenue up 12%; margin steady at 4.4%.
- Capex raised
Guidance moves to $6 billion to fund automation and debottlenecking.
- Supply pact signed
Multi-year agreement with Titan Company at index-linked pricing.
- Groundbreaking
Construction at the new facility near Mundra begins.
- First production
Targeted within 20 months of groundbreaking.
Analysts were broadly constructive. Of 18 brokerages covering the stock, 12 maintain buy ratings, with target prices implying about 13.7% upside. The more cautious voices pointed to a valuation premium and the execution risk inherent in a large expansion programme.
Expert commentary
“We are building where the customers are asking us to build. That is the simplest capital-allocation rule there is.”
“The data is clear on direction and less clear on pace. I would plan for slower and be pleasantly surprised.”
“In my conversations with procurement heads, reliability is mentioned three times for every mention of price.”
Risks and analyst view
A new long-term agreement with Titan Company anchors a portion of the expansion. The deal covers multi-year supply at index-linked pricing, with volume commitments that provide a floor, and includes a joint development programme for higher-specification products with better margins.
What it means for you
Order visibility and a manageable balance sheet support the story; track execution on the new plant and margin pass-through.
Expansion will lift procurement; engage early on qualification for the new lines.
Longer-term agreements offer price stability in exchange for volume commitments; compare index-linked terms carefully.
About 1,200 direct roles and a technician academy are planned near Mundra; applications open with the state skills portal.
Companies and leaders in this story
Frequently asked questions
Sources
- UN Comtrade: Bilateral trade flows by HS code
- Ministry of Commerce & Industry: Monthly trade statistics and notifications
- Company filings and earnings calls: Disclosures on order books and capex
- Directorate General of Foreign Trade: Export-import policy and public notices
Mock content for demonstration. Names, figures and quotes are illustrative and not real reporting.
